Clinical Trial: Baveno VII criteria-guided initiation of non-selective beta blocker in patients with compensated advanced chronic liver disease to reduce hepatic decompensation: an open-label randomised controlled trial (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Baveno VII criteria-guided initiation of non-selective beta blocker in patients with compensated advanced chronic liver disease to reduce hepatic decompensation: an open-label randomised controlled trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129799

Registration Time: 2026/08/10

Type: Interventional study

Primary Sponsor: Beijing Friendship Hospital ,Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337185

Published by HT Digital Content Services with permission from Health Daily Digest....